Target intelligence / Profile preview

Skin surface and stratum corneum proteins and lipids (SC)

Target
SC
Molecular classification
Structural protein, Lipid, Other
01

Overview

The skin surface and stratum corneum (SC) represent the outermost layer of the epidermis, serving as the body's primary physical and chemical barrier against environmental stressors [StatPearls: NBK513299]. This structure is characterized by a bricks and mortar arrangement, where protein-rich corneocytes are embedded in a continuous matrix of specialized lipids, including ceramides, cholesterol, and free fatty acids [PubMed: 18254807]. The protein component is largely composed of keratin filaments and the cornified envelope, which provides structural rigidity and a scaffold for lipid attachment [PMC3175844]. Biological functions of this layer include preventing transepidermal water loss (TEWL), maintaining acidic pH to inhibit pathogen growth, and facilitating desquamation through enzymatic degradation of corneodesmosomes [PMC2835893]. In diseases such as atopic dermatitis, psoriasis, and ichthyosis, alterations in protein expression (e.g., filaggrin) or lipid composition lead to barrier failure and chronic inflammation [PubMed: 24656726]. Therapeutic strategies involve the use of emollients to restore lipid integrity, humectants to enhance hydration, and keratolytic agents to manage hyperkeratosis [PMC3175844]. Consequently, the stratum corneum is a major focus for topical drug delivery and dermatological health maintenance.

Other names
Stratum corneumSkin barrierHorny layerCornified envelopeEpidermal barrier
02

Mechanism of action

Drugs targeting the skin surface and stratum corneum act by physically sealing the surface (occlusion), attracting water into the tissue (humectancy), filling gaps between cells (emolliency), or chemically breaking down structural proteins to facilitate shedding (keratolysis) [StatPearls: NBK513299, PMC3175844].

03

Biological functions

Barrier functionImmune responseOther
04

Disease associations

InflammationInfectionOther
05

Safety considerations

Skin irritationAllergic contact dermatitisDisruption of skin microbiomeIncreased systemic absorption of co-administered substances
06

Interacting drugs

Urea

6 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)CorneometrySkin surface pH

Beyond the preview

Go deeper on Skin surface and stratum corneum proteins and lipids (SC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin surface and stratum corneum proteins and lipids (SC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call